| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.11 | 0.5 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.047 | 0.5 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.5 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.5 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |